FWM
BIO icon

Focused Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Focused Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$646 – 291
2023
Q4 		$646 Hold
2
– – ﹤0.01% 887
2023
Q3 		$717 Hold
2
– – ﹤0.01% 881
2023
Q2 		$758 Hold
2
– – ﹤0.01% 916
2023
Q1 		$958 Hold
2
– – ﹤0.01% 874
2022
Q4 		$841 Hold
2
– – ﹤0.01% 892
2022
Q3 		$1K Hold
2
– – ﹤0.01% 814
2022
Q2 		$1K Hold
2
– – ﹤0.01% 797
2022
Q1 		$1K Buy
+2
New +$1.21K ﹤0.01% 854

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $43.1B AUM 23.42% 1-Year Est. Return